StrayLight's Virtual Theater
Uncovers the Secrets of
Monoclonal Antibodies
for Abbott Labs

Thousands of Doctors Virtually Voyage
Inside a Knee Joint

Warren, NJ, USA, Jan 28, 2002 - StrayLight Corp. has developed and delivered a detailed 3D stereoscopic production for Abbott Labs, presenting a detailed scientific review of therapies for rheumatoid arthritis, culminating with the presentation of an exciting, new fully human monoclonal antibody treatment which Abbott has in development. This 3D experience is delivered at trade shows using StrayLight's proprietary 3D Virtual Theater, a group of 10 Virtual Reality stations consisting of professional grade head mounted displays, sound system, and motion based chairs. The Abbott theater made its debut at the American College of Rheumatology (ACR) Conference, San Francisco, Nov 12-14, 2001 and will continue to be featured at domestic and international shows in 2002.

Thousands of Rheumatologists at ACR were "injected" inside an inflamed knee joint to witness the debilitating effects of rheumatoid arthritis. StrayLight's Virtual Theater transported Abbott's guests down to the cellular level to see the degeneration of bone and cartilage at an unusually high level of detail. The 3D stereoscopic effects helped to orient these virtual visitors to the microscopic perspective inside the knee.

Trade show attendees were then virtually shrunk down even further to become part of a cellular surface landscape, entering into the molecular actions of the complex process of rheumatoid arthritis and the various therapies used to treat this disease. Starting with the molecular mechanism of action of conventional therapies, the Virtual Theater presentation progresses through a series of increasingly advanced approaches to the treatment of rheumatoid arthritis. Some of the most promising approaches involve monoclonal antibodies, synthesized versions of the human body's own defense system. Earlier monoclonal antibody treatments use varying portions of the antibody from non-human sources, often from mice. Abbott Labs research centers have been leading the way toward a fully human monoclonal antibody treatment for rheumatoid arthritis, and StrayLight's Virtual Theater presentation demonstrates many of the results of this research.

StrayLight is the industry leader in custom designed Virtual Reality systems for entertainment, promotions and special events. StrayLight's VR systems have been installed worldwide for numerous Virtual Reality tours and marketing events, and have a proven track record of efficiency and reliability. With product lines ranging from interactive VR game platforms to group 3-D Virtual Theater experiences, StrayLight has developed over 45 custom VR productions. A sample of StrayLight's customers include: ABBOTT Laboratories, AT&T, AVIS, Blockbuster Entertainment, CableTron Systems, Chase Bank, Danzka Vodka, Disney Resorts, First Union, Frontier Communications, IBM Corp., Grateful Dead, Hennessy Cognac, Hoechst Celanese, ITT Educational Services, Jim Beam Brands, Kraft Foods, Merck, Nabisco, Novo Nordisk, Oracle, Parke-Davis, Pfizer, PGA Tour, Royal Caribbean, Steel Recycling Institute, TAP Pharmaceuticals, UCB Pharma, USA Networks, and Warner-Lambert.

International Partners Wanted

New VR Theater
Launch at ADA

VR Experience
for Kidney Disease

3D Ride Film
On Tour

VR Headlines
Michigan State

Copyright (c) 2007
StrayLight Corp.